Share on StockTwits

Cytosorbents Corp (NASDAQ:CTSO) Director Al Kraus unloaded 50,000 shares of the company’s stock on the open market in a transaction that occurred on Monday, July 7th. The stock was sold at an average price of $0.24, for a total value of $12,000.00. Following the transaction, the director now directly owns 1,393,631 shares in the company, valued at approximately $334,471. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Separately, analysts at Zacks reiterated an “outperform” rating on shares of Cytosorbents Corp in a research note on Friday, May 16th. They now have a $0.50 price target on the stock.

Cytosorbents Corp (NASDAQ:CTSO) opened at 0.24 on Thursday. Cytosorbents Corp has a 52-week low of $0.08 and a 52-week high of $0.35. The stock’s 50-day moving average is $0.24 and its 200-day moving average is $0.22. The company’s market cap is $71.8 million.

CytoSorbents Corporation is a development stage critical care focused company using blood purification to treat life-threatening illnesses.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.